1-20 of 5403
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DOACs: role of anti-Xa and drug level monitoring

Siraj Mithoowani, Deborah Siegal
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 178–185.
https://doi.org/10.1182/hematology.2024000666
Published: 2024
Journal Articles

Troubleshooting heparin resistance

Cheryl L. Maier, Jean M. Connors, Jerrold H. Levy
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 186–191.
https://doi.org/10.1182/hematology.2024000659
Published: 2024
Journal Articles

Warfarin and heparin monitoring in antiphospholipid syndrome

Prabal Mittal, Zara Sayar, Hannah Cohen
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 192–199.
https://doi.org/10.1182/hematology.2024000547
Published: 2024
Journal Articles

Common variable immunodeficiency: autoimmune cytopenias and advances in molecular diagnosis

Charlotte Cunningham-Rundles, Jean-Laurent Casanova, Bertrand Boisson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 137–142.
https://doi.org/10.1182/hematology.2024000538
Published: 2024
Journal Articles

Sickle cell disease in India: the journey and hope for the future

Kalpna Gupta, Lakshmanan Krishnamurti, Dipty Jain
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 1–9.
https://doi.org/10.1182/hematology.2024000678
Published: 2024
Journal Articles

Mutation- and MRD-informed treatments for transplant-ineligible patients

Curtis A. Lachowiez, Courtney D. DiNardo
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 168–177.
https://doi.org/10.1182/hematology.2024000540
Published: 2024
Journal Articles

Transfusions, disease-modifying treatments, and curative therapies for sickle cell anemia in Africa: where are we now?

Isaac Odame, Godwin Nosakhare Bazuaye
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 234–239.
https://doi.org/10.1182/hematology.2024000550
Published: 2024
Journal Articles

Large granular lymphocyte leukemia: a clonal disorder with autoimmune manifestations

Tony Marchand, Cédric Pastoret, Aline Moignet, Mikael Roussel, Thierry Lamy
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 143–149.
https://doi.org/10.1182/hematology.2024000539
Published: 2024
Journal Articles

Mutations and MRD: clinical implications of clonal ontogeny

Jerald Radich
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 150–157.
https://doi.org/10.1182/hematology.2024000541
Published: 2024
Journal Articles

New definitions for antiphospholipid syndrome: ready for clinical use?

Evidence-Based Minireview
Andrew B. Song, Rebecca K. Leaf
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 222–226.
https://doi.org/10.1182/hematology.2024000673
Published: 2024
Journal Articles

Mutation- and MRD-informed treatment decisions for the transplant-eligible AML patient

Michael Heuser, Rabia Shahswar
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 158–167.
https://doi.org/10.1182/hematology.2024000542
Published: 2024
Journal Articles

Patient-reported outcomes after CAR T-cell therapy in patients with hematological malignancies

Xin Shelley Wang, Samer A. Srour
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 102–108.
https://doi.org/10.1182/hematology.2024000536
Published: 2024
Journal Articles

Anandappa A, Curran E. Challenges to successful outcomes in AYAs with ALL and potential solutions. Hematology Am Soc Hematol Educ Program . 2023;2023(1):587-592.

A Anandappa, E Curran
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 744.
https://doi.org/10.1182/hematology.2024E04
Published: 2024
Journal Articles

Biology of post-transplant relapse: actionable features

Giorgio Orofino, Luca Vago
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 736–743.
https://doi.org/10.1182/hematology.2024000588
Published: 2024
Journal Articles

How to think about acute leukemia of ambiguous lineage

Olga K. Weinberg
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 287–292.
https://doi.org/10.1182/hematology.2024000554
Published: 2024
Journal Articles

Sharing is caring: a network collaborative approach to identify and address barriers in accessing clinical trials in adolescents and young adults with leukemia and lymphoma

Caroline Hesko, Jessica Heath, Michael E. Roth, Nupur Mittal
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 27–33.
https://doi.org/10.1182/hematology.2024000526
Published: 2024
Journal Articles

The role of stem cell transplant (auto and allo) in PTCL and CTCL

Peter Dreger, Norbert Schmitz
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 69–77.
https://doi.org/10.1182/hematology.2024000670
Published: 2024
Journal Articles

ITP in pregnancy: diagnostics and therapeutics in 2024

Annemarie E. Fogerty
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 685–691.
https://doi.org/10.1182/hematology.2024000595
Published: 2024
Journal Articles

Predicting bispecific antibody failure in diffuse large B-cell lymphoma

Evidence-Based Minireview
Allison Barraclough, Eliza A. Hawkes
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 318–320.
https://doi.org/10.1182/hematology.2024000677
Published: 2024
Journal Articles

Treatment of VTE in the thrombocytopenic cancer patient

Florian Moik, Cihan Ay
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2024) 2024 (1): 259–269.
https://doi.org/10.1182/hematology.2024000551
Published: 2024
Includes: Supplemental data